linkstream2 microblog

http://scienceblog.cancerresearchuk.org/2014/08/27/mustard-gas-from-the-great-war-to-frontline-chemotherapy/

http://www.nejm.org/doi/full/10.1056/NEJM199310283291801#t=article

QT:{{”
When treated with effective multiagent chemotherapy, about two thirds of children with newly diagnosed acute lymphoblastic leukemia survive for long periods of time1-4. Much of this success can be credited to more intensive early treatment, especially of patients at higher risk of relapse.
“}}

Result of Pinkel ’79 study

https://en.wikipedia.org/wiki/Henry_Kaplan_(doctor)

https://en.wikipedia.org/wiki/Thomas_Hodgkin

QT:{{"
Thomas Hodgkin (17 August 1798 – 5 April 1866) was a British physician, considered one of the most prominent pathologists of his time and a pioneer in preventive medicine. He is now best known for the first account of Hodgkin’s disease, a form oflymphoma and blood disease, in 1832.[1] Hodgkin’s work marked the beginning of times when a pathologist was actively involved in the clinical process. He was a contemporary of Thomas Addison and Richard Bright at Guy’s Hospital.

"}}

https://en.wikipedia.org/wiki/VAMP_regimen

https://en.wikipedia.org/wiki/Vincristine

https://en.wikipedia.org/wiki/Min_Chiu_Li

QT:{{"
Min Chiu Li (Chinese: 李敏求; pinyin: Lǐ Mǐnqiú; 1919–1980) was a Chinese-American oncologist and cancer researcher. Li was the first scientist to use chemotherapy to cure widely metastatic, malignant cancer.[3]

"}}

https://en.wikipedia.org/wiki/Austin_Bradford_Hill

QT:{{"
Sir Austin Bradford Hill FRS[1] (8 July 1897 – 18 April 1991), English epidemiologistand statistician, pioneered the randomized clinical trial and, together with Richard Doll, demonstrated the connection between cigarette smoking and lung cancer. Hill is widely known for pioneering the "Bradford Hill" criteria for determining a causal association.[2][3]

"}}

http://www.nytimes.com/2013/05/05/science/emil-frei-iii-who-put-cancer-cures-in-reach-dies-at-89.html?_r=0

QT:{{"
In the mid-1950s, Dr. Frei, along with Dr. Emil J. Freireich, a colleague at the National Cancer Institute, and others, began investigating a multipronged assault on childhood leukemia that entailed using these drugs in combination, with each attacking a different aspect of cancer-cell physiology.

"}}

https://en.wikipedia.org/wiki/Mary_Lasker